ARCHIVES

Weekly Paclitaxel Better Than Every Three Weeks

This article is from The Cancer Letter archive.

Vol. 27 No. 6 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

Three New RFAs Announced In Cancer Control

November 3, 1978

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

NIEHS Conference to Look At 21st Century Issues

April 1, 1988